Fused bicyclic heteroaryl compounds as NLRP3 inhibitors

The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物,#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GUBA, WOLFGANG, AITKEN LINDA SUE, SHANNON JONATHAN MARTIN, PATINY-ADAM, ANDR, JAESCHKE GEORG, JOHNSTON, H., JOHN, MESCH, SCOTT, K, SCHNIEDER CHRISTIAN, STEINER SANDRA, TOSTOV ALEXANDER MIKHAILOVICH, BUSH LAWRENCE A
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GUBA, WOLFGANG
AITKEN LINDA SUE
SHANNON JONATHAN MARTIN
PATINY-ADAM, ANDR
JAESCHKE GEORG
JOHNSTON, H., JOHN
MESCH, SCOTT, K
SCHNIEDER CHRISTIAN
STEINER SANDRA
TOSTOV ALEXANDER MIKHAILOVICH
BUSH LAWRENCE A
description The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物,#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所述;包含所述化合物的组合物;以及使用所述化合物的方法。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118119626A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118119626A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118119626A3</originalsourceid><addsrcrecordid>eNrjZDB3Ky1OTVFIykyuTM7JTFbISC1JLcpPLKrMUUjOzy3IL81LKVZILFbw8wkKMFbIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoYWhoaWZkZmjsbEqAEAu60tsg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fused bicyclic heteroaryl compounds as NLRP3 inhibitors</title><source>esp@cenet</source><creator>GUBA, WOLFGANG ; AITKEN LINDA SUE ; SHANNON JONATHAN MARTIN ; PATINY-ADAM, ANDR ; JAESCHKE GEORG ; JOHNSTON, H., JOHN ; MESCH, SCOTT, K ; SCHNIEDER CHRISTIAN ; STEINER SANDRA ; TOSTOV ALEXANDER MIKHAILOVICH ; BUSH LAWRENCE A</creator><creatorcontrib>GUBA, WOLFGANG ; AITKEN LINDA SUE ; SHANNON JONATHAN MARTIN ; PATINY-ADAM, ANDR ; JAESCHKE GEORG ; JOHNSTON, H., JOHN ; MESCH, SCOTT, K ; SCHNIEDER CHRISTIAN ; STEINER SANDRA ; TOSTOV ALEXANDER MIKHAILOVICH ; BUSH LAWRENCE A</creatorcontrib><description>The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物,#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所述;包含所述化合物的组合物;以及使用所述化合物的方法。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240531&amp;DB=EPODOC&amp;CC=CN&amp;NR=118119626A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240531&amp;DB=EPODOC&amp;CC=CN&amp;NR=118119626A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GUBA, WOLFGANG</creatorcontrib><creatorcontrib>AITKEN LINDA SUE</creatorcontrib><creatorcontrib>SHANNON JONATHAN MARTIN</creatorcontrib><creatorcontrib>PATINY-ADAM, ANDR</creatorcontrib><creatorcontrib>JAESCHKE GEORG</creatorcontrib><creatorcontrib>JOHNSTON, H., JOHN</creatorcontrib><creatorcontrib>MESCH, SCOTT, K</creatorcontrib><creatorcontrib>SCHNIEDER CHRISTIAN</creatorcontrib><creatorcontrib>STEINER SANDRA</creatorcontrib><creatorcontrib>TOSTOV ALEXANDER MIKHAILOVICH</creatorcontrib><creatorcontrib>BUSH LAWRENCE A</creatorcontrib><title>Fused bicyclic heteroaryl compounds as NLRP3 inhibitors</title><description>The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物,#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所述;包含所述化合物的组合物;以及使用所述化合物的方法。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3Ky1OTVFIykyuTM7JTFbISC1JLcpPLKrMUUjOzy3IL81LKVZILFbw8wkKMFbIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoYWhoaWZkZmjsbEqAEAu60tsg</recordid><startdate>20240531</startdate><enddate>20240531</enddate><creator>GUBA, WOLFGANG</creator><creator>AITKEN LINDA SUE</creator><creator>SHANNON JONATHAN MARTIN</creator><creator>PATINY-ADAM, ANDR</creator><creator>JAESCHKE GEORG</creator><creator>JOHNSTON, H., JOHN</creator><creator>MESCH, SCOTT, K</creator><creator>SCHNIEDER CHRISTIAN</creator><creator>STEINER SANDRA</creator><creator>TOSTOV ALEXANDER MIKHAILOVICH</creator><creator>BUSH LAWRENCE A</creator><scope>EVB</scope></search><sort><creationdate>20240531</creationdate><title>Fused bicyclic heteroaryl compounds as NLRP3 inhibitors</title><author>GUBA, WOLFGANG ; AITKEN LINDA SUE ; SHANNON JONATHAN MARTIN ; PATINY-ADAM, ANDR ; JAESCHKE GEORG ; JOHNSTON, H., JOHN ; MESCH, SCOTT, K ; SCHNIEDER CHRISTIAN ; STEINER SANDRA ; TOSTOV ALEXANDER MIKHAILOVICH ; BUSH LAWRENCE A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118119626A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GUBA, WOLFGANG</creatorcontrib><creatorcontrib>AITKEN LINDA SUE</creatorcontrib><creatorcontrib>SHANNON JONATHAN MARTIN</creatorcontrib><creatorcontrib>PATINY-ADAM, ANDR</creatorcontrib><creatorcontrib>JAESCHKE GEORG</creatorcontrib><creatorcontrib>JOHNSTON, H., JOHN</creatorcontrib><creatorcontrib>MESCH, SCOTT, K</creatorcontrib><creatorcontrib>SCHNIEDER CHRISTIAN</creatorcontrib><creatorcontrib>STEINER SANDRA</creatorcontrib><creatorcontrib>TOSTOV ALEXANDER MIKHAILOVICH</creatorcontrib><creatorcontrib>BUSH LAWRENCE A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GUBA, WOLFGANG</au><au>AITKEN LINDA SUE</au><au>SHANNON JONATHAN MARTIN</au><au>PATINY-ADAM, ANDR</au><au>JAESCHKE GEORG</au><au>JOHNSTON, H., JOHN</au><au>MESCH, SCOTT, K</au><au>SCHNIEDER CHRISTIAN</au><au>STEINER SANDRA</au><au>TOSTOV ALEXANDER MIKHAILOVICH</au><au>BUSH LAWRENCE A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fused bicyclic heteroaryl compounds as NLRP3 inhibitors</title><date>2024-05-31</date><risdate>2024</risdate><abstract>The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物,#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所述;包含所述化合物的组合物;以及使用所述化合物的方法。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN118119626A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Fused bicyclic heteroaryl compounds as NLRP3 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A40%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GUBA,%20WOLFGANG&rft.date=2024-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118119626A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true